Attached files

file filename
8-K - TAIWAN FUND INCfp0008269_8k.htm
 

 
THE TAIWAN FUND,  INC. (THE ‘FUND’)
 
MONTHLY INSIGHT
 
 
AUGUST 31, 2013
 
IN BRIEF
 
Net asset value per share
US$19.30
Market price
US$17.33
Premium/(discount)
(10.21%)
Total net assets
US$158.7m
Market cap
US$142.5m
 
Source: State Street Bank and Trust Company.   
 
At August 31, 2013
 
US$ return
 
Fund*
%
TAIEX Total Return Index
%
One month
(0.3)
(0.1)
Three months
3.1
(0.1)
One year
12.1
11.7
Three years % pa
7.2
7.8
 
Returns are annualized, except for periods of less than one year.
 
*
Source: State Street Bank and Trust Company.
NAV performance.
 
Source: TWSE.
 
Past performance is not a guide to future returns.
 
FUND MANAGERS
 
 
Wong Kok Hoi
 
James Liu
 
 
MANAGER’S COMMENTARY
 
The TAIEX  fell by 0.1% in August, partly  due to selling  pressure from  foreign institutional funds (concerned about  the potential tapering of US quantitative easing), coinciding with  low trading volumes. Material  sectors like rubber, wire and cable,  as well as construction were  the weaker performers over the month.
 
Towards the end of 2012, the Taiwan  government temporarily stopped the approval of local insurance firms  buying domestic commercial property, due to concerns about compressing yields and an overheating of local commercial property prices.  Over  the past few months, however, the prospect of a potential early end to US monetary-stimulus measures has meant that the outlook on yields in alternative asset classes has changed, and the purchasing behavior of local insurance firms  has shifted. As a result, the government decided in August to once  again  allow insurance companies to invest in Taiwan  commercial property.
 
Our  view is that this will help support the value of commercial property assets in Taiwan, which would have positive  implications for a number of companies in the portfolio that own  such  assets.  However, given  how  much property prices  have risen since the global  financial crisis, we are keeping a close eye on yield rates and price trends  in the Taiwan  property market, and using  only conservative forecasts in our stock  valuation modeling. By so doing, we seek to avoid either  paying  too much for potential new  additions to the portfolio or holding onto  stocks  that have become overvalued.
 
 
 

 
 
MONTHLY INSIGHT
 
INVESTMENT REVIEW
 
The Fund’s net asset value fell 0.3% in US dollar  terms  over the month. Among the Fund’s best performers were  the pharmaceutical group YungShin Global  Holding, materials company Taiflex  Scientific and technology firm Advantech.
 
YungShin Global  recently won  the rights  to distribute the drug  AmBiL  in Taiwan, and to manufacture it for global  distribution. AmBiL, a generic drug used to treat a life-threatening condition where fungi  enter  the bloodstream, has received the Taiwan  authorities’ green light for the local market, and is awaiting approval for entry  into the EU and US markets. Revenues are expected to begin  streaming from  each  region in 2014  and 2015, respectively. Elsewhere, Taiflex  Scientific performed strongly after  it reported yet another month of strong sales growth in July. Advantech also fared  well after  it reported a good set of results  in the second quarter, with  15% year-on- year earnings growth on the back  of 8%  sales growth and margin expansion.
 
On the other  side, notable detractors included office-equipment supplier Aurora and Mercuries & Associates, which operates retail stores as well as securities and insurance businesses. Aurora’s share  price  slid along  with  the general market. However, the company has posted strong year-to-date performance and is still on track  to grow  its office automation and furniture business in China by strengthening its distribution network. Meanwhile, Mercuries & Associates also performed poorly  in August, despite having  reported a solid set of results for the first half of 2013. Investor  concern centers on the company’s loss-making mini-mart and department-store businesses, and management’s plan to open  another 1,000 mini-marts within three years. However, its insurance business has been  improving, and the stock  trades  at an attractive valuation: a trailing  price/earnings ratio of 12x and a price/book value ratio of about  1.3x for the 2013 fiscal year. We will hold  onto  the position at the current share  price.
 
Source: Martin Currie Inc. and APS Asset Management Pte Ltd.
 
For further information please go to www.thetaiwanfund.com.
Martin Currie Inc. took over management of the Fund on May 9, 2010.
 
 
 

 
 
FUND DETAILS
 
August 31, 2013
Shares outstanding
8,221,259
Exchange listed
NYSE
Listing date
1986
Investment manager
Martin Currie Inc.
 
Source: State Street Bank and Trust Company.
 
PERFORMANCE
 
 
(US$ RETURNS)
(US$ returns)
NAV %
Market price %
One month
(0.3)
0.7
Three months
3.1
3.8
Three years % pa
7.2
7.2
 
Returns are annualized, except for periods of less than one year.
Source: State Street Bank and Trust Company.
 
Past performance is not a guide to future returns.
 

 
SECTOR ALLOCATION
 
 
Fund  %*
Benchmark %
Electronics
31.0
49.0
Wholesale and  retail
14.1
5.2
Construction
12.7
2.2
Healthcare
9.5
  —
Textiles
6.5
2.0
Electric  and  machinery
4.6
1.5
Others
4.3
3.3
Transportation
4.0
1.9
Finance
3.9
14.0
Plastics
3.7
7.2
Steel  and  iron
2.6
Chemicals
2.3
Foods
2.1
Rubber
1.9
Automobile
1.8
Cement
1.4
Tourism
0.6
Electrical appliance and  cable
0.4
Glass and ceramics
0.3
Paper  and pulp
0.3
Other assets  and  liabilities,  net
5.7
 
*
Source: State Street Bank and Trust Company.
Source: TWSE.
 
15 LARGEST HOLDINGS*
 
64.4% of holdings
Sector
% of net assets
WT Microelectronics
Electronics
7.7
Yungshin Global  Holding
Healthcare
6.4
Taiwan  Semiconductor Manufacturing
Electronics
5.6
Aurora
Electronics
4.8
Yungtay Engineering
Electric  and machinery
4.6
Advantech
Electronics
4.3
Mercuries & Associates
Wholesale and retail
4.2
PC Home Online
Wholesale and retail
3.8
Yem  Chio
Plastics
3.7
Taiflex  Scientific
Electronics
3.6
Makalot Industrial
Textiles
3.5
Taiwan  Tea
Wholesale and retail
3.2
Pacific  Hospital Supply
Healthcare
3.1
Far Eastern  New Century
Textiles
3.0
Test-Rite International
Wholesale and retail
2.9
 
*
Source: State Street Bank and Trust Company.
 
 
 

 
 

 
PERFORMANCE
(US$ returns at August 31, 2013)
 
 
One month
%
Three months
%
Calendar year
to date
%
One year
%
Three years
% pa
Five years
% pa
Ten years
% pa
Since launch
% pa
The Taiwan  Fund,  Inc.*
(0.3)
3.1
7.9
12.1
7.2
5.6
6.7
8.7
TAIEX  Index
(0.9)
(2.8)
1.1
8.6
4.1
3.7
5.0
8.3
TAIEX  Total Return Index
(0.1)
(0.1)
4.0
11.7
7.8
7.4
8.9
na
MSCI  Taiwan  Index
(0.2)
(1.3)
2.4
11.4
7.7
5.6
6.4
na
 
Returns are annualized, except for periods of less than one year.
*
Source: State Street Bank and Trust Company. Launch date December 23, 1986. Returns for the Fund are historical total returns that reflect changes in net asset value per share during each period and assume that dividends and capital gains, if any, were reinvested.
Source: MSCI for the MSCI Taiwan Index and TWSE for the TAIEX Total Return Index and the TAIEX Index. For a full description of each index please see the index descriptions section.
 
Returns for the TAIEX Index are not total returns and reflect only changes in the share price but do not assume that cash dividends, if any, were reinvested, and thus are not strictly comparable to the Fund returns.
 
The TAIEX Total Return Index commenced January 1, 2003.
 
Past performance is not a guide to future returns.
 
 
 

 
 
MONTHLY INSIGHT
 
PORTFOLIO IN FULL
 
Sector
Company
(BGB ticker)
Price NT$
Holding
Value  US$
% of
net assets
ELECTRONICS
       
31.0
WT Microelectronics
3036  TT
33.6
10,901,900
12,222,719
7.7
Taiwan  Semiconductor Manufacturing
2300  TT
100.5
2,626,000
8,819,295
5.6
Aurora
2373  TT
56.4
4,060,000
7,652,058
4.8
Advantech
2395  TT
152.0
1,335,100
6,781,574
4.3
Taiflex  Scientific
8039  TT
49.7
3,452,821
5,728,836
3.6
MPI
6223  TT
53.5
1,448,000
2,588,782
1.6
King  Slide Works
2059  TT
254.0
285,000
2,419,088
1.5
Lumax  International
6192  TT
66.4
844,000
1,872,766
1.2
Tatung
2371  TT
7.3
4,770,897
1,155,876
0.7
           
WHOLESALE AND  RETAIL
       
14.1
Mercuries & Associates
2905  TT
20.1
9,912,429
6,658,084
4.2
PC Home Online
8044  TT
170.0
1,048,128
5,954,377
3.8
Taiwan  Tea
2913  TT
18.7
8,231,000
5,143,601
3.2
Test-Rite International
2908  TT
22.8
6,075,260
4,618,696
2.9
           
CONSTRUCTION
       
12.7
Goldsun Development & Construction
2504  TT
11.3
11,314,980
4,253,823
2.7
King’s Town  Construction
2524  TT
28.3
4,474,764
4,224,368
2.7
Acter
5536  TT
118.0
941,179
3,711,311
2.3
Taiwan  Land  Development
2841  TT
11.2
8,681,129
3,249,132
2.0
Hung Poo Real Estate  Development
2536  TT
29.3
2,465,873
2,414,412
1.5
Good Friend  International Holdings
912398 TT
10.0
6,990,000
2,324,199
1.5
           
HEALTHCARE
       
9.5
YungShin Global  Holding
3705  TT
49.5
6,146,000
10,166,486
6.4
Pacific  Hospital Supply
4126  TT
107.0
1,345,456
4,810,900
3.1
           
TEXTILES
       
6.5
Makalot Industrial
1477  TT
161.5
1,030,000
5,558,823
3.5
Far Eastern  New Century
1402  TT
32.2
4,430,207
4,759,684
3.0
           
ELECTRIC AND  MACHINERY
       
4.6
Yungtay Engineering
1507  TT
69.4
3,134,000
7,268,278
4.6
 
 
 

 
 
Sector
Company
(BGB ticker)
 
Price NT$
 
Holding
 
Value  US$
% of net assets
OTHER
       
4.3
Ruentex Development
9945  TT
59.1
1,734,314
3,425,219
2.2
Taiwan  Secom
9917  TT
71.0
728,000
1,727,280
1.1
Taiwan  Sogo  Shinkong Security
9925  TT
36.1
1,378,000
1,662,377
1.0
           
TRANSPORTATION
       
4.0
First Steamship
2601  TT
18.3
6,677,714
4,072,525
2.6
Taiwan  High  Speed Rail
2633  TT
5.5
12,597,600
2,311,177
1.4
           
FINANCE
       
3.9
Yuanta Financial  Holding
2885  TT
15.0
6,321,000
3,168,474
2.0
Union Bank of Taiwan
2838  TT
10.6
8,523,207
3,004,890
1.9
           
PLASTICS
       
3.7
Yem  Chio
4306  TT
23.0
7,647,915
5,878,195
3.7
           
OTHER ASSETS AND  LIABILITIES,  NET
     
9,085,079
5.7
 
 
 

 
 
MONTHLY INSIGHT
 
THE TAIWAN FUND, INC. PREMIUM/DISCOUNT
 
 
Source: State Street Bank and Trust Company as of August 31, 2013.
 

 
INDEX DESCRIPTIONS
 
TAIEX Index
The TWSE, or TAIEX Index is a capitalization-weighted index of all listed common shares traded on the Taiwan Stock Exchange. The Index was based in 1966 and does not include re-invested dividends.
 
TAIEX Total Return Index
The TAIEX Total Return Index is a capitalization-weighted index of all listed common shares traded on the Taiwan Stock Exchange, based in 1966, which includes re-invested dividends.
 
MSCI Taiwan Index
The MSCI Total Return Taiwan Index is a free-float adjusted market capitalization index. The Index represents Taiwanese companies that are available to investors worldwide. The Index has a base date of December 31, 1987. As of August 31, 2013, it contained 107 constituents.
 

  
OBJECTIVE
 
The Fund was launched on December 23, 1986 to allow US and other investors to access and participate in the growth of the economy and the stock market in Taiwan, the Republic of China. The Fund’s investment objective is to seek long-term capital appreciation primarily through investments in equity securities listed in Taiwan. The Fund is a diversified, closed-end management investment company listed on the New York Stock Exchange (NYSE) under the symbol ‘TWN’.
 
Taiwan, with its global market leadership in high technology goods and its significant investments throughout mainland China and Southeast Asian economies, is now an integral economic player in the Asia Pacific Region as well as around the world. Investing in Taiwan not only allows investors to capitalize on Taiwan’s dynamic economy, but also allows investors to reap the growth and investment potential of the mainland China and other emerging economies of the region.
 
 
 

 
 
CONTACTS

 
The Taiwan Fund, Inc.
c/o State Street Bank and Trust Company
2 Avenue de Lafayette
PO Box 5049
Boston, MA 02111
Tel: (1) 877-864-5056
 
www.thetaiwanfund.com
 

  
IMPORTANT INFORMATION

This document is issued and approved by Martin Currie Inc. (‘MC Inc.’), as investment adviser of The Taiwan Fund, Inc. (the ‘Fund’). MC Inc. is authorised and regulated by the Financial Conduct Authority (‘FCA’) and incorporated under limited liability in New York, USA. Registered in Scotland (No BR2575), registered address Saltire Court, 20 Castle Terrace, Edinburgh, EH1 2ES. Information herein is believed to be reliable but has not been verified by MC Inc. MC Inc. makes no representation or warranty and does not accept any responsibility in relation to such information or for opinion or conclusion which the reader may draw from this newsletter.
 
The Fund is classified as a diversified investment company under the US Investment Company Act of 1940 as amended. It meets the criteria of a closed ended US fund and its shares are listed on the New York Stock Exchange. MC Inc. has been appointed investment adviser to the Fund.
 
Investors are advised that they will not generally benefit from the rules and regulations of the United Kingdom Financial Services and Markets Act 2000 and the FCA for the protection of investors, nor benefit from the United Kingdom Financial Services Compensation Scheme, nor have access to the Financial Services Ombudsman in the event of a dispute. Investors will also have no rights of cancellation under the FCA’s Conduct of Business Sourcebook of the United Kingdom.
 
This newsletter does not constitute an offer of shares. MC Inc., its ultimate and intermediate holding companies, subsidiaries, affiliates, clients, directors or staff may, at any time, have a position in the market referred to herein, and may buy or sell securities, currencies, or any other financial instruments in such markets. The information or opinion expressed in this newsletter should not be construed to be a recommendation to buy or sell the securities, commodities, currencies or financial instruments referred to herein.
 
The information provided in this report should not be considered a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased.
 
It should not be assumed that any of the securities transactions or holdings discussed here were or will prove to be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of the securities discussed herein.
 
Investing in the Fund involves certain considerations in addition to the risks normally associated with making investments in securities. The value of the shares issued by the Fund, and the income from them, may go down as well as up and there can be no assurance that upon sale, or otherwise, investors will receive back the amount originally invested. There can be no assurance that you will receive comparable performance returns, or that investments will reflect the performance of the stock examples contained in this document. Movements in foreign exchange rates may have a separate effect, unfavorable as well as favorable, on the gain or loss otherwise experienced on an investment. Past performance is not a guide to future returns. Accordingly, the Fund is only suitable for investment by investors who are able and willing to withstand the total loss of their investment. In particular, prospective investors should consider the following risks:
 
It should be noted that investment in the Fund is only suitable for sophisticated investors who are aware of the risk of investing in Taiwan and should be regarded as long term. Funds which invest in one country carry a higher degree of risk than those with portfolios diversified across a number of markets.
 
Investment in the securities of smaller and unquoted companies can involve greater risk than is customarily associated with investment in larger, more established, companies. In particular, smaller companies often have limited product lines, markets or financial resources and their management may be dependent on a smaller number of key individuals. In addition, the market for stock in smaller companies is often less liquid than that for stock in larger companies, bringing with it potential difficulties in acquiring, valuing and disposing of such stock. Proper information for determining their value, or the risks to which they are exposed, may not be available.
 
Investments within emerging markets such as Taiwan can be of higher risk. Many emerging markets, and the companies quoted on their stock exchanges, are exposed to the risks of political, social and religious instability, expropriation of assets or nationalization, rapid rates of inflation, high interest rates, currency depreciation and fluctuations and changes in taxation which may affect the Fund’s income and the value of its investments.
 
The marketability of quoted shares may be limited due to foreign investment restrictions, wide dealing spreads, exchange controls, foreign ownership restrictions, the restricted opening of stock exchanges and a narrow range of investors. Trading volume may be lower than on more developed stockmarkets, and equities are less liquid. Volatility of prices can also be greater than in more developed stockmarkets. The infrastructure for clearing, settlement and registration on the primary and secondary markets may be undeveloped. Under certain circumstances, there may be delays in settling transactions in some of the markets.
 
 
 
 
Martin Currie Inc. registered in Scotland (no BR2575)
 
Registered office: Saltire Court, 20 Castle Terrace, Edinburgh EH1 2ES
Tel: 44 (0) 131 229 5252 Fax: 44 (0) 131 228 5959 www.martincurrie.com
 
North American office: 1350 Avenue of the Americas, Suite 3010, New York, NY
10019, USA Tel: (1) 212 258 1900 Fax: (1) 212 258 1919
 
Authorised and regulated by the Financial Conduct Authority and incorporated with limited liability in New York, USA. Registered with the SEC as an investment adviser.
 
Please note: calls to the above numbers may be recorded.